Loading...

IDXX - IDEXX Laboratories, Inc.

Analyst Downgrade Signal for 05-05-2022
Analyst Downgrade Signal: IDXX from Buy to Neutral by BofA Securities
Price Target: $550>>470



Stock Signal Information


Signal

Analyst Downgrade Stock
Report Date: 05-05-2022
Symbol: IDXX - IDEXX Laboratories, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Analyst Downgrade Signal: IDXX from Buy to Neutral by BofA Securities
Price Target: $550>>470

  IDXX Technical Chart

Company Contact

IDEXX Laboratories, Inc. (IDXX)
1 Idexx Dr
Westbrook, MAINE 04092
Phone: 12075560300
Website: http://www.idexx.com
CEO: Mr. Jonathan Mazelsky


Company Profile

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.